Simplex Trading’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,504
| Closed | -$36K | – | 9890 |
|
|
2025
Q3 | $36K | Sell |
6,504
-22,713
| -78% | -$116K | ﹤0.01% | 6786 |
|
|
2025
Q2 | $111K | Buy |
+29,217
| New | +$90.7K | ﹤0.01% | 5131 |
|
|
2024
Q4 | – | Sell |
-14,618
| Closed | -$56K | – | 9500 |
|
|
2024
Q3 | $66K | Buy |
+14,618
| New | +$70.7K | ﹤0.01% | 5638 |
|
|
2024
Q1 | – | Sell |
-3,251
| Closed | -$18.2K | – | 9760 |
|
|
2023
Q4 | $20K | Buy |
+3,251
| New | +$18.6K | ﹤0.01% | 6945 |
|
|
2023
Q3 | – | Sell |
-23,528
| Closed | -$185K | – | 9683 |
|
|
2023
Q2 | $239K | Buy |
23,528
+16,036
| +214% | +$167K | ﹤0.01% | 4093 |
|
|
2023
Q1 | $67K | Sell |
7,492
-19,357
| -72% | -$142K | ﹤0.01% | 5595 |
|
|
2022
Q4 | $192K | Buy |
26,849
+5,630
| +27% | +$34.4K | ﹤0.01% | 4278 |
|
|
2022
Q3 | $138K | Sell |
21,219
-38,696
| -65% | -$207K | ﹤0.01% | 5085 |
|
|
2022
Q2 | $288K | Buy |
59,915
+36,759
| +159% | +$182K | ﹤0.01% | 4148 |
|
|
2022
Q1 | $131K | Buy |
23,156
+22,617
| +4,196% | +$111K | ﹤0.01% | 5768 |
|
|
2021
Q4 | $2K | Buy |
+539
| New | +$2.97K | ﹤0.01% | 10047 |
|
Simplex Trading's SCPH Position: Q4 2025 in Review
Simplex Trading sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 6,504 shares — an estimated $36K sold.
Simplex Trading first reported a position in SCPH in Q4 2021 and held it in 11 quarters. The position peaked at $288K in Q2 2022. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Simplex Trading reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 6,504 scPharmaceuticals shares in Q4 2025, an estimated $36K.
- Simplex Trading first reported a position in scPharmaceuticals in Q4 2021 and held it in 11 quarters.
- Simplex Trading's scPharmaceuticals position peaked at $288K in Q2 2022.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.